Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with small molecule expertise focusing on oral dosage forms. With a proven history in drug delivery, Adare has developed and manufactures more than 45 products sold by customers worldwide.

Services & Capabilities
Adare provides end-to-end CDMO services, from clinical trial materials and product development to commercial manufacturing and packaging. We can develop and manufacture oral dose products from start to finish, and we can tech transfer pre-established projects into our facilities.

Adare’s industry-leading experts possess unparalleled experience in the development of unique patient-centric dosage forms that provide taste masking, controlled release, and solubility enhancement capabilities. Our technology platforms address unique formulation challenges to deliver complex and layered solutions for large patient populations with unique needs, including pediatrics, geriatrics, and dysphagic patients.

Adare operates seven facilities in the US and Europe, staffed by nearly 800 employees. With our global manufacturing network, Adare is capable of serving markets throughout the world. From our state-of-the-art facilities in the US and Europe, we can provide development-scale through commercial-scale production, with a continuum of highly specialized manufacturing services and capabilities to meet any customer’s oral solid dose needs.